1. Home
  2. BCAL vs VALN Comparison

BCAL vs VALN Comparison

Compare BCAL & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southern California Bancorp

BCAL

Southern California Bancorp

N/A

Current Price

$21.13

Market Cap

699.7M

Sector

Finance

ML Signal

N/A

Logo Valneva SE

VALN

Valneva SE

N/A

Current Price

$5.37

Market Cap

582.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BCAL
VALN
Founded
2001
2012
Country
United States
France
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
699.7M
582.2M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
BCAL
VALN
Price
$21.13
$5.37
Analyst Decision
Buy
Buy
Analyst Count
4
4
Target Price
★ $24.75
$12.28
AVG Volume (30 Days)
★ 154.2K
16.3K
Earning Date
10-28-2026
11-24-2026
Dividend Yield
★ 2.24%
N/A
EPS Growth
★ 777.27
N/A
EPS
★ 1.30
N/A
Revenue
N/A
N/A
Revenue This Year
$1.29
N/A
Revenue Next Year
$6.46
$87.84
P/E Ratio
$16.53
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.87
$4.75
52 Week High
$22.59
$12.18

Technical Indicators

Market Signals
Indicator
BCAL
VALN
Relative Strength Index (RSI) 38.56 41.89
Support Level $20.60 $5.16
Resistance Level $22.00 $5.52
Average True Range (ATR) 0.50 0.20
MACD -0.08 -0.01
Stochastic Oscillator 18.42 7.36

Price Performance

Historical Comparison
BCAL
VALN

About BCAL Southern California Bancorp

California BanCorp is a relationship-focused community bank offering commercial loan and deposit products, along with other services delivered directly or through strategic alliances, to business and individual customers in its target markets. The Company provides financial products and services to individuals, professionals, and small to medium-sized businesses through its branch and commercial banking offices serving California. Its lending products consist mainly of construction and land development loans, real estate loans, C&I loans, and consumer loans, and it is a Preferred SBA Lender, while its deposit products consist mainly of demand deposit, money market, and certificates of deposit. The Company operates in one reportable segment, commercial banking.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: